ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Advancements in DNA-Driven Precision Modulation of Cell Surface Receptor for Programmable Cellular Functions.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Advanced integrated SERS-based strategies for the early diagnosis of upper gastrointestinal cancers.Journal of nanobiotechnology · 2026Review
- From Blueprint to Breakthrough: How Far Can We Fold DNA Origami for Nano-Enabled Technologies?JACS Au · 2026Review
- AND-Logic-Gated Aptamer Switch for Precise Targeting and Regulation of RNA G-Quadruplexes.Angewandte Chemie (International ed. in English) · 2026Article
- Synthetic mechanoreceptor engineering: From genetic encoding to DNA nanotechnology-based reprogramming.Mechanobiology in medicine · 2025Review
- Advancements in DNA-Driven Precision Modulation of Cell Surface Receptor for Programmable Cellular Functions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Precise modulation of receptor-mediated signaling is essential for understanding cellular communication and developing targeted therapeutics. Receptor engineering strategies focus on enhancing specificity, manipulating allosteric effects, and controlling receptor clustering. This review comprehensively summarizes recent advances in DNA-based strategies as versatile platforms for receptor engineering, encompassing both genetic and non-genetic approaches. Genetic approaches leverage DNA's protein-coding capability to reprogram receptor function through techniques like domain fusion and site-directed mutagenesis. Complementarily, non-genetic strategies exploit the structural and functional properties of DNA to achieve multidimensional control over receptor functionalities. Specifically, functional nucleic acids (FNAs) confer novel and customizable molecular recognition responsiveness, while DNA nanostructures, such as DNA origami, provide nanoscale spatial precision for regulating receptor valency and oligomerization. Furthermore, programmable dynamic DNA reactions facilitate the development of nanodevices responsive to diverse stimuli, including proteins, small molecules, ions, light, and mechanical forces. Notably, emerging DNA-based logic circuits and nanorobots offer programmable and autonomous control over receptor signaling. Looking forward, integrating genetic and non-genetic DNA engineering strategies holds significant promise at the interface of synthetic biology and DNA nanotechnology, driving the development of next-generation intelligent cellular systems for precise medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.